To identify the potential molecular mechanism by which rpS6 overactivation affects the clinical development of NSCLC, cells biological activities with rpS6 lentivirus mediated interference were analyzed subsequently. This evidence concerns the gene RPS6 and non-small cell lung carcinoma.